Dianthus Therapeutics (DNTH)

Dianthus Therapeutics (DNTH) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• DNTH last traded at $81.62, -0.92% on the day.
• Dianthus Therapeutics: P/E -627.9, revenue $1.90M over the last four quarters.
• Over the past year DNTH returned 141.92%; year to date 98.07%.

Updated 2026-11-02 19:50 UTC